An initial analysis suggests that the Pfizer-BioNTech SARS-CoV-2 vaccine could reduce viral load and, in turn, perhaps viral transmission, the Guardian reports.
An initial analysis suggests that the Pfizer-BioNTech SARS-CoV-2 vaccine could reduce viral load and, in turn, perhaps viral transmission, the Guardian reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.